Startup Details

Matt Handel

CEO

ExpressCells

Company Name

ExpressCells

Company Website

http://ExpressCells

Industry

Biotechnology

Location

UNITED STATES

Developmental Stage

*********

Approx Revenue for current Year

*********

Type of funding

*********

Pre-money Valuation (USD)

*********

Type of offering

*********

Amount of Capital seeking in current round (USD)

*********

Previous capital raised (USD)

*********

Monthly Burn rate (USD)

*********

Company Description

ExpressCells is a genetic-editing biotech that creates custom & catalog cell lines for biological research. We use CRISPR plus our patented plasmid system in our proprietary lab to create better cell lines and we do so faster than older technologies. We have over 20 customers and are expanding our distribution internationally. We sell through e-c... Read more

Product/Service Description

We create genetically-edited cell lines for use by biological researchers, often in small pharma & biotech. While we can perform all types of genetic edits, our leading services is knock-in cell lines: cells with genes inserted. We create reporters (cells with knocked-in fluorescent genes), overexpression models, and cells with point mutations. We ... Read more

Management Team

Matt Handel

CEO

Matthew Handel

CEO

Shamim Naghdi

Scientific Director

Connie Davies

Controller & Financial Advisor

Oscar Perez-Leal

Co-Founder & Scientific Advisor

Rob Hart

Operations Lead

Advisor Team

Previous Investors

Ronjon Nag

Managing Partner

Tony Sarris

Executive Director, Orange County

Victoria Dominguez-Eddington

Director

Ellen Weber

Executive Director

David Becker

President

Matthew Handel

CEO

Ernie Holtzheimer

Manager

Company Information

Date Company Founded
09/04/2018
Registered Location
Delaware
Legal Name
ExpressCells, Inc.
Date Company Registered
09/04/2018
Address
, Philadelphia, Pennsylvania
Country